Fig. 3From: Monitoring serum HER2 levels in breast cancer patientsDisease free survival of breast cancer patients after surgery. Kaplan-Meier analyses showing the association of preoperative sHER2 with adverse patient outcome in two cohorts using recurrence-free survival as clinical endpointsBack to article page